TITLE

FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine

PUB. DATE
April 2009
SOURCE
MMWR: Morbidity & Mortality Weekly Report;4/17/2009, Vol. 58 Issue 14, p374
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the U.S. Food and Drug Administration (FDA) has approved on December 4, 2008 an expanded age indication for the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) Boostrix. This vaccine is licensed for use on persons ranging from 10 to 64 years old as a single-dose booster immunization. Indications for use of Boostrix are also cited which include single dose of Tdap for 11- to 18-year-old persons who completed the recommended childhood diphtheria and tetanus toxoids and pertussis vaccine.
ACCESSION #
38216453

 

Related Articles

  • FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diptheria Toxoid and Acellular Pertussis Vaccine.  // JAMA: Journal of the American Medical Association;8/26/2009, Vol. 302 Issue 8, p841 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to approve an expanded age indication for the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) Boostrix from GlaxoSmithKline Biologicals. Boostrix is indicated for people aged 10 to...

  • Whooping cough vaccine approved for adults.  // Mayo Clinic Health Letter;Oct2005, Vol. 23 Issue 10, p4 

    Reports on the decision of the U.S. Food and Drug Administration to approve a booster vaccine against whooping cough, diphtheria and tetanus in 2005. Nature of whooping cough; Relative merits of the vaccine according to Mayo Clinic doctors.

  • First Whooping Cough Vaccine for Adolescents.  // FDA Consumer;Jul/Aug2005, Vol. 39 Issue 4, p2 

    Announces that in May 2005, the U.S. Food & Drug Administration (FDA) has approved Boostrix, the first vaccine for adolescents that provides a booster immunization against whooping cough or pertussis in combination with tetanus and diphtheria. Age group targeted by Boostrix; Side effects of the...

  • FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine.  // JAMA: Journal of the American Medical Association;11/2/2011, Vol. 306 Issue 17, p1856 

    The article reports on the U.S. Food and Drug Administration's (FDA) approval of expanded age indication for Boostrix, a vaccine against tetanus, diphtheria, and pertussis licensed for persons aged 10 through 64 years, to include persons aged 65 years and older. The indications and guidance...

  • New Whooping Cough Vaccines For Adolescents And Adults.  // RN;Jul2005, Vol. 68 Issue 7, p78 

    The article reports that the U.S. Food & Drug Administration (FDA) has approved Boostrix, the first combination booster vaccine for adolescents that offers protection against pertussis (whooping cough), tetanus, and diphtheria. Previous combination booster vaccines for adolescents protected...

  • New Whooping Cough Vaccine for Adolescents and Adults.  // FDA Consumer;Sep/Oct2005, Vol. 39 Issue 5, p6 

    Reports on the approval of Adacel, a vaccine for adolescents and adults that provides a single booster immunization against cough in combination with tetanus and diphtheria, by the U.S. Food and Drug Administration (FDA) in June 2005. Composition of the drug; Information on Boostrix, a vaccine...

  • FDA Approves Boostrix To Prevent Tetanus, Diphtheria & Pertussis In Older People.  // Biomedical Market Newsletter;7/14/2011, p1 

    The article reports on the approval of Boostrix vaccine, which prevents tetanus, diphtheria, and pertussis in elderly, by the U.S. Food and Drug Administration (FDA) on July 8, 2011. It says that the vaccine was the first approved immunizing agent that keeps all three diseases in people ages 65...

  • Diptheria and Tetanus Toxoids and Pertussis Vaccine.  // Annals of Internal Medicine;Feb72, Vol. 76 Issue 2, p289 

    Presents recommendations of the U.S. Public Health Service Advisory Committee regarding immunization practices against diphtheria, tetanus and pertussis. Preparations used for immunization; Details of vaccine usage; Description of tetanus propylaxis in wound management.

  • Childhood immunization. Ford, Carolyn; Howard, Akima; White, Gina // Drug Store News;1/11/99, Vol. 21 Issue 1, pCP19 

    Provides an overview of basic principles and practices of pediatric immunization therapy. Review of the immune response; Agents used to provide immunity; Diphtheria, tetanus and pertussis vaccines; Haemophilus influenzae type b; Hepatitis B; Measles, mumps and rubella; Poliomyelitis; Varicella;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics